HeyJaredBriceyda Landaverde
- Indexed articles, last 90 days
- 5
- Latest publication
- Sep 24, 2026
- Outlet visibility, for NBC Connecticut
- Top 500K sites
- Earliest in this view
- Aug 18, 2026
Latest articles
Cancer diagnoses are rising in people under 50. When should you get screened? (opens the original)
Read excerpt
With cancer diagnoses among younger adults on the rise, are current cancer screening guidelines keeping pace? Health experts say that early detection and screenings can help save lives. But for people who develop cancer before reaching the recommended screening age, recognizing symptoms and speaking with a doctor can be especially important. Stream Connecticut News for free, 24/7, wherever you are. "If you are experiencing symptoms, regardless of your age, you should speak with your doctor about
Beyond the Scale: GLP-1 medications show promise for women with PMOS (opens the original)
Read excerpt
A hormonal and metabolic condition long known as PCOS has a new name, and doctors say GLP-1 medications could offer another treatment option for some women living with the condition. PMOS stands for polyendocrine metabolic ovarian syndrome and affects about one in eight women. Stream Connecticut News for free, 24/7, wherever you are. Symptoms can include irregular periods, polycystic ovaries, and high levels of androgens, which can lead to extra hair growth. Insulin resistance can also play a ro
Beyond the Scale: A discussion on the research, risks, benefits, and impact of GLP-1s (opens the original)
Read excerpt
All this week, NBC Connecticut’s Beyond the Scale series has explored the research, risks, and benefits surrounding GLP-1 medications. NBC Connecticut’s Briceyda Landaverde, Taylor Regan, and Eddie Randle were in the studio on Friday to discuss some of the biggest questions surrounding GLP-1s and what researchers are learning. Stream Connecticut News for free, 24/7, wherever you are. Eddie Randle: So all this week, we've been exploring the research, the risks, and the benefits behind GLP-1s in o
Beyond the Scale: Endometriosis patients report relief after using GLP-1s (opens the original)
Read excerpt
Women with endometriosis have long relied on surgery or hormone medications to manage their symptoms, but now, doctors are exploring a new option: GLP-1 medications. While it is not FDA approved to treat the condition, one woman says it has helped her get back to living her life. Savannah Regensberger recently captured the attention of thousands of women on social media after sharing her own experience of taking a GLP-1 for the chronic condition. She's very open about her battle with the disease
Beyond the Scale: What are ‘Ozempic babies'? How GLP-1s may impact fertility (opens the original)
Read excerpt
The term “Ozempic babies” has been circulating on social media after women taking GLP-1 medications reported unexpected pregnancies. “A lot of patients are going on these GLP-1 medications primarily to lose weight, and there's been an uptick in unintended pregnancies due to it,” Dr. Jason Schneider with UConn Health said. Stream Connecticut News for free, 24/7, wherever you are. MotherToBaby, a national nonprofit organization, is collecting research on GLP-1 medications and women’s fertility. Sh
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For NBC Connecticut, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.